Litcius/Paper detail

Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment–Elevation Myocardial Infarction (STEMI)

Antonio Abbate, Benjamín Van Tassell, Vladimir Bogin, Roshanak Markley, Д. В. Певзнер, Paul Cremer, I. Meray, Dmitry V. Privalov, Angela M. Taylor, S. A. Grishin, Alina N. Egorova, Еkaterina G. Ponomar, Yan Lavrovsky, Samsonov MIu, A. S. Pisaryuk, L. Babaeva, I.T. Zyuryaev, Denis Kalimulin, O. M. Lapin, Sergei Mekhriakov, М. М. Попов, Igor Kalashnikov, Ekaterina Duhanina, S.D. Osmanova, Egor Kornilov, Ekaterina Zubova, Vakhtang Safarian, Н. М. Селезнева, Ekaterina Savelieva, O. G. Privalova, Zaur Shogenov, V. M. Novosadov, M. M. Agirov, Rostislav Nilk, Andrey Fedash, А. М. Yurkovskiy, Anastasia Kotova, И Н Староверов, V. M. Mayorov, Oxana Lonchakova, Denis Rozanov, S. S. Yаkushin, S. V. Seleznev, Е. А. Pravkina, К. G. Pereverzeva, Г. Т. Иванова, Jeremy Turlington, Georgia Thomas, Azita H. Talasaz, Michele Golino, Marco Giuseppe Del Buono, Amr Marawan, Juan Ignacio Damonte

2024Circulation22 citationsDOI

Topics & Concepts

MedicineMyocardial infarctionPlaceboCardiologyInternal medicineBlockadeDouble blindReceptorPathologyAlternative medicineInflammasome and immune disordersAcute Myocardial Infarction ResearchIL-33, ST2, and ILC Pathways
Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment–Elevation Myocardial Infarction (STEMI) | Litcius